The civil complaint, filed in federal court in Philadelphia, alleged AmerisourceBergen and two of its subsidiaries failed to comply with these laws and could have failed to report hundreds of thousands of potentially suspicious orders.The company is accused of ignoring alerts from its red flag system and continuing to sell to pharmacies, knowing they might be diverting some prescription drugs to illicit markets."[T]he company's repeated and systemic failure to fulfill this simple obligation helped ignite an opioid epidemic that has resulted in hundreds of thousands of deaths over the past decade," DEA Administrator Anne Milgram said in a news release Thursday.In a statement, the company said the Justice Department's lawsuit focuses on five pharmacies that are "cherry picked" out of tens of thousands of pharmacies it works with and ignores the DEA's "absence of action.""In fact, AmerisourceBergen terminated relationships with four of them before DEA ever took any enforcement action while two of the five pharmacies maintain their DEA controlled substance registration to this day," the company said."